Curative Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Employees
  • 7,000
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.7M
Latest Deal Amount
  • Investors
  • 7

Curative General Information

Description

Provider of COVID-19 testing services designed to offer coronavirus test kits. The company's services offer COVID-19 test which is a simple, painless and self-administered oral fluid swab, enabling customers to conduct self-administered tests at home by using flocked cotton swabs and scalable extraction methods that do not rely on supply-constrained magnetic silica beads.

Contact Information

Website
www.curative.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Primary Office
  • 430 South Cataract Avenue
  • San Dimas, CA 91773
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Curative Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 23-Sep-2020 $8.7M 00.00 000.00 Completed Startup
To view Curative’s complete valuation and funding history, request access »

Curative Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A7 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A6 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A5 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A4 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A3 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A1 2,399,980 $0.000010 $0.04 $0.04 1x $0.04 5.26%
Series A 2,955,300 $0.000010 $0.85 $0.85 1x $0.85 6.25%
To view Curative’s complete cap table history, request access »

Curative Executive Team (7)

Name Title Board Seat Contact Info
Fred Turner Chief Executive Officer & Co-Founder
Tami Wilson-Ciranna Chief Financial Officer
Christopher Vanek Chief Operating Officer
Lee Spraggon Ph.D Chief Technology Officer
Vlad Slepnev Ph.D Chief Scientific Officer & Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

Curative Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curative Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
DCVC Venture Capital Minority 000 0000 000000 0
Eren Bali Angel (individual) Minority 000 0000 000000 0
Justin Mateen Angel (individual) Minority 000 0000 000000 0
Lauder Partners Venture Capital Minority 000 0000 000000 0
Litani Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Curative Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000 19-May-2020 000000000000000000 Laboratory Services (Healthcare) 0000 000000
To view Curative’s complete acquisitions history, request access »

Ready to get started?

Request a free trial